UBS Group AG

Holdings History for Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX)

Symbol
AMRX on Nasdaq
Investment type
Equity / Class A Common Stock, par value $0.01
Latest Disclosed Shares Owned
0 shares
Security Ownership %
0%
Shares, Excluding Options vs Price
Value, Excluding Options

UBS Group AG ownership in Amneal Pharmaceuticals, Inc. Class A Common Stock, par value $0.01 (AMRX)

10 Feb 2025 - UBS Group AG has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Amneal Pharmaceuticals, Inc. Class A Common Stock, par value $0.01 (AMRX). This represents 0% ownership of the company. In their previous filing dated 30 Oct 2024, UBS Group AG had reported owning 21,491,881 shares, indicating a decrease of +100%. .
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.